Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Abstract : Mutations in Cu/Zn superoxide dismutase (encoded by SOD1), one of the causes of familial amyotrophic lateral sclerosis (ALS), lead to progressive death of motoneurons through a gain-of-function mechanism. RNA interference (RNAi) mediated by viral vectors allows for long-term reduction in gene expression and represents an attractive therapeutic approach for genetic diseases characterized by acquired toxic properties. We report that in SOD1(G93A) transgenic mice, a model for familial ALS, intraspinal injection of a lentiviral vector that produces RNAi-mediated silencing of SOD1 substantially retards both the onset and the progression rate of the disease.
Type de document :
Article dans une revue
Nature Medicine, Nature Publishing Group, 2005, 11 (4), pp.423-8. 〈10.1038/nm1207〉
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00484530
Contributeur : Roman Tyzio <>
Soumis le : mardi 18 mai 2010 - 15:28:32
Dernière modification le : mardi 30 janvier 2018 - 01:00:43
Document(s) archivé(s) le : jeudi 1 décembre 2016 - 00:44:00

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Cédric Raoul, Toufik Abbas-Terki, Jean-Charles Bensadoun, Sandrine Guillot, Georg Haase, et al.. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.. Nature Medicine, Nature Publishing Group, 2005, 11 (4), pp.423-8. 〈10.1038/nm1207〉. 〈inserm-00484530〉

Partager

Métriques

Consultations de la notice

432